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Abstract: It is unclear whether diabetic ketoacidosis (DKA) severity at diagnosis affects the natural
history of type 1 diabetes (T1D). We analysed associations between DKA severity at diagnosis and
glycaemic control during the first year post-diagnosis. We followed 341 children with T1D, <19 years
(64% non-white) attending paediatric diabetes clinics in East London. Data were extracted from
routine medical registers. Subjects were categorized with normal, mild, moderate, or severe DKA.
Linear mixed-effects modelling was used to assess differences in longitudinal HbA1c trajectories
(glycaemic control) during 12 months post-diagnosis (1288 HbA1c data-points) based on DKA,
adjusting for sex, age, ethnicity, SES (Socioeconomic Status) and treatment type. Females (OR 1.6,
95% CI 1.1–2.4) and younger age, 0–6 vs. 13–18 years (OR 2.9, 95% CI 1.5–5.6) had increased risk for
DKA at diagnosis. Moderate or severe DKA was associated with higher HbA1c at diagnosis (adjusted
estimates 8 mmol/mol, 2–14, and 10 mmol/mol, 4–15, respectively, compared to normal DKA).
Differences in HbA1c trajectories by DKA were no longer apparent at six months post-diagnosis.
All subjects experienced a steep decrease in HbA1c during the first three months followed by a gradual
increase. While, DKA severity was not associated with glycaemic control at 12 months post-diagnosis,
age at diagnosis, ethnicity, gender, and treatment type were significantly associated. For example,
Black and mixed ethnicity children had increased risk for poor glycaemic control compared to
White children (adjusted RRR 5.4, 95% CI 1.7–17.3 and RRR 2.5, 95% CI 1.2–6.0, respectively).
DKA severity at diagnosis is associated with higher initial HbA1c but not glycaemic control from
six months post-diagnosis. Age at diagnosis, ethnicity, gender, and insulin pump are associated with
glycaemic control at one year post-diagnosis.
Keywords: type 1 diabetes; diabetic ketoacidosis; glycaemic control; ethnicity; inequalities;
longitudinal analysis
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1. Introduction
Children with type 1 diabetes (T1D) demonstrate considerable clinical variation at diagnosis
despite the vast majority having lost most of their beta-cell function (60–80% of beta-cells stop
producing insulin) [1,2]. Progressive reduction in endogenous insulin production results in metabolic
derangements leading to life threatening hyperglycaemia, volume depletion, electrolyte imbalance,
and formation of ketone bodies culminating in diabetic ketoacidosis (DKA). DKA severity at diagnosis
varies considerably between patients and is affected by delayed diagnosis, younger age (<5 years),
ethnic minority, and lower socioeconomic status (SES) [1,3]. Individual variability in DKA ranges from
mild with minimal dehydration and acidosis to severe with excessive dehydration and acidosis [1].
Observational studies demonstrate long-term tracking of poor glycaemic control from diagnosis
which is associated with increased risk for chronic micro- and macro-vascular complications [4–9].
Several factors at diagnosis are associated with poor glycaemic control during the first two
years including ketoacidosis severity, younger age, gender, humoral immune responses, SES,
ethnicity, and psychosocial factors such as parental involvement, psychosocial maturity, and family
situation [2,10–12]. Studies on ketoacidosis severity at diagnosis and poorer glycaemic control are
limited and report conflicting results. Additionally, the association between ketoacidosis severity
and glycaemic control is confounded by age at diagnosis as younger children present with greater
ketoacidosis severity but lower glycated haemoglobin (HbA1c) [2,13].
We investigated longitudinal relationships between ketoacidosis severity at diagnosis and
glycaemic control during the first year post-diagnosis in a multi-ethnic cohort of subjects attending
pediatric diabetes clinics in East London. We also investigated factors associated with ketoacidosis at
diagnosis and glycaemic control at 12 months post-diagnosis. We aimed to identify subjects with a
“high risk” profile; presenting with greater ketoacidosis at diagnosis and poor early glycaemic control.
This may enable developing targeted interventions for improving glycaemic control in such patients
earlier on and is important as poor early glycaemic control tracks into young adulthood.
2. Patients and Methods
2.1. Design, Setting, and Data Source
We designed a longitudinal cohort study of newly diagnosed patients with T1D using data from
three paediatric diabetes clinics that are part of the same Healthcare Trust (Barts Health NHS Trust)
located in East London, UK [14]. The clinics largely capture patients living in surrounding areas of
East London, where ~56% of the local population belongs to an ethnic minority, with around 50% of
South Asian origin (primarily Bangladeshi) and 40% of Black origin (primarily Somali) [15].
The study was restricted to children <19 years of age who received a diagnosis of T1D between
1 January 2005 and 31 December 2015 and attended one of the three clinics during this period. Clinical
and sociodemographic data were collected prospectively, both at the time of diagnosis and during
routine clinic visits. As recommended by the National Institute of Health and Care Excellence (NICE),
a child with T1D is offered an integrated package of care by a multidisciplinary team at a paediatric
diabetes clinic four times/year. The team consists of paediatric endocrinologists/diabetologists,
diabetes specialist nurses, dieticians, psychologists, interpreters, and a database manager. HbA1c
levels are recorded at each visit. All demographic and clinical parameters are systematically measured
and electronically documented across the clinics enabling comparison. A total of 598 children were
diagnosed with T1D during the study period, of whom 580 (97%) had complete data on sex, age at
diagnosis, duration of diabetes, and ethnicity and were eligible to be included in the analysis.
2.2. Primary Outcome, Exposures, and Covariates
The primary outcome was glycaemic control measured by glycated haemoglobin or HbA1c
levels. HbA1c was measured at each visit using the point of care Siemens/Bayer DCA 2000+
Analyzer. HbA1c values recorded as percentages were converted to mmol/mol (formula: HbA1c value
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in %−2.15) × 10.929). Subjects were classified as having good (HbA1c <58 mmol/mol), moderate
(HbA1c 58–79 mmol/mol) and poor (HbA1c ≥80 mmol/mol) glycaemic control.
The primary exposure was DKA severity at diagnosis measured by pH levels and the pH value
(blood capillary samples) measured closest to initial presentation was used. Based on the ISPAD
(International Society for Pediatric and Adolescent Diabetes) Clinical Practise Consensus Guidelines,
subjects were grouped into normal (pH ≥ 7.3), mild (pH 7.2–7.29), moderate (pH 7.1–7.19), and severe
(pH < 7.1) DKA [1]. These are also the national guidelines for the definition of DKA in the UK as
recommended by NICE [16].
Covariates included age at diagnosis, sex, ethnicity, SES, treatment type, and clinic attended.
Participants (or their parents) self-identified their ethnicity (choosing 1 of 15 categories or the option to
decline identifying their ethnicity) during clinic visits. We used the first recorded entries for ethnicity
at the time of diagnosis. The 15 ethnic categories were collapsed into four broad groups: White,
mixed-ethnicity (any mixed ethnicity combination), Black, and Asian (any Asian origin) reflecting
the ethnic distribution of the study area in East London. The latter group included subjects mostly
of Bangladeshi, Pakistani, and some Indian origin and a small proportion originating from other
Asian countries.
SES was derived from postcode of residence using indices of multiple deprivation (IMD) 2010
for England [17]. The IMD is a small geographical area measure of deprivation with scores derived
from a weighted combination of indicators across seven measures of deprivation including income,
employment, education skills and training, health, barriers to housing and services, living environment,
and crime. IMD scores are calculated at the level of lower-layer super output areas, with each area
comprising 1500 individuals on average. Lower IMD rank scores indicate higher levels of deprivation.
Age at diagnosis was calculated by subtracting date of diagnosis from date of birth. Duration of
diabetes was calculated in months by subtracting the date at first visit in the audit year from the date of
diagnosis of T1D. For some analysis, age at diagnosis was categorised into 0–6, 7–12, and 13–18 years.
Treatment type was a dichotomous variable with subjects categorised into insulin pump or non-insulin
pump therapy.
2.3. Statistical Analysis
Baseline characteristics were compared across all DKA groups. Categorical variables were
compared as frequencies using Chi2 or Fisher’s Exact test (if numbers ≤5). Mean differences in
baseline continuous variables by DKA were analysed using simple linear regression. We tested for
a trend in continuous variables (age at diagnosis, pH levels, and HbA1c) across the different DKA
groups using the Stata command “nptrend” (which uses an extension of the Wilcoxon rank-sum test for
trend across ordered groups).
We used multivariable logistic regression to analyse factors (categorical age at diagnosis, sex,
ethnicity, and SES (quartiles)) associated with DKA at diagnosis (defined as pH < 7.3).
Linear mixed effects modelling (growth curve analysis) was used to assess whether HbA1c
trajectories differed by DKA at diagnosis over the first 12 months post-diagnosis. This enables
comparison of population average HbA1c levels and change over time for the three DKA categories
while controlling for covariates. We approximated time trends using a cubic model for time since
diagnosis as this provided a better statistical fit compared to linear and quadratic models. We first
fit a random intercept model (i.e., an unconditional means model) to define the intraclass correlation
coefficient (ICC). This was compared to a random intercept and random slope model which had
a better fit and was used in subsequent models. DKA at diagnosis (categorical), ethnicity, age at
diagnosis (continuous), sex, SES (continuous), and diabetes clinic were entered as time-invariant
predictors whereas treatment regimen was entered as time-variant. We ran four models: Model 1:
Random intercept only (unconditional model); Model 2: unadjusted growth model with a cubic
function of time since diagnosis (disease duration) as the time metameter; Model 3: adjusted for our
primary predictor; DKA at diagnosis and additionally an interaction term between DKA and duration
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(to assess whether DKA status interacts with duration on mean HbA1c trajectories) and Model 4:
additionally adjusted for sex, age at diagnosis, ethnicity, treatment type, SES, and diabetes clinic
attended. The model with an interaction between DKA status and linear duration only was chosen as
it had a better fit than the model including interactions with higher order polynomials (quadratic and
cubic duration). Additionally, both interaction models had a very similar visual fit. Model parameters
were estimated by maximum likelihood and a heterogeneous autoregressive covariance structure was
used in all models. We used generalized likelihood ratio statistics, −2 log-likelihood (−2 LL), Aikake
information criterion (AIC), and sample-adjusted Bayesian information criterion (BIC) to compare
model fit between subsequent nested models, and Wald statistics to test hypotheses about model
parameters. We plotted cubic growth curves at the group level (i.e., DKA status at diagnosis) from the
model with linear interaction terms to visualise model fit.
2.4. Factors Associated with Glycaemic (HbA1c) 12 Months Post-Diagnosis
We calculated relative risk ratios (RRR) of moderate (HbA1c 58–79 mmol/mol) and poor (HbA1c
≥80 mmol/mol) glycaemic control with good control as the baseline, comparing those with DKA
to no DKA at diagnosis using multivariable multinomial logistic regression. We ran two models:
Model 1—minimally adjusted for DKA at diagnosis only; and Model 2—additionally adjusted for sex,
age at diagnosis, ethnicity, treatment type, and paediatric diabetes clinic attended.
2.5. Sensitivity Analysis
We compared the study sample of 364 children with data on pH at diagnosis with those missing
data on pH at diagnosis (N = 126) to ensure that results were generalizable to the eligible population
(N = 580, of whom 490 had pH data).
All analyses were run in Stata 13 (StataCorp LLC, Lakeway Drive, College Station, TX, USA).
For this study, all participants were anonymized making them unidentifiable. The study is
registered with the R and D Office, GOS Institute of Child Health, UCL (University College London)
(Project number 14PP08).
3. Results
Of the 580 children with data on various covariates, 490 children had at least one recorded HbA1c
value within the first 12 months post-diagnosis. Of these, 126 children were missing data on pH at
diagnosis, leaving a final sample of 364 with data on all other covariates for inclusion in analysis. There
were no significant differences in age and HbA1c at diagnosis between the study sample (N = 364) and
those excluded because of missing data on pH (N = 126). We observed no significant differences in
the distribution of cases by gender, ethnicity, and clinic attended between the study sample and those
excluded because of missing data (Supplemental Table S1).
Mean age at diagnosis was 8.8 years. 41% presented with any form of DKA (pH≤ 7.2) at diagnosis.
Females and younger children were more likely to present with lower pH levels at diagnosis.
For example, mean age at diagnosis was two years lower in the severe compared to the normal
DKA groups (7.5 vs. 9.6 years, p < 0.001, Table 1). The severe, moderate and mild DKA groups had
higher HbA1c levels at diagnosis compared to the normal group, but differences were not statistically
significant. However, a test for trend of HbA1c levels across the DKA categories was statistically
significant (p = 0.03, Table 1). There were no differences in proportions between the three DKA groups
by ethnicity, SES, or diabetes clinic attended.
3.1. Factors Associated with DKA at diagnosis
Females and those younger at diagnosis had increased odds to present with DKA (pH < 7.3).
Compared to males, females had a 60% increased risk to present with DKA. Those aged 0–6 and
7–12 years at diagnosis had significantly increased odds to present with DKA (OR 2.9, 95% CI
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1.5–5.6 and OR 2.3, 95% CI 1.2–4.3 respectively, Table 2) compared to those aged 13–18 years. Ethnicity
and SES were not associated with risk of DKA at diagnosis.
Table 1. Characteristics of 364 children and young people diagnosed with type 1 diabetes between
2005 and 2015 and attending paediatric diabetes clinics in East London. Values are means (SD)
or proportions.
Covariate
Diabetic Ketoacidosis at Diagnosis Statistical Significance
Normal
(pH≥ 7.3)
Mild
(pH 7.2–7.29)
Moderate
(pH 7.1–7.19)
Severe
(pH < 7.1) All p-Value
d p-Value e
N 214 53 42 55 364
Age at diagnosis, continuous (Years) 9.6 (4.1) 7.9 (4.2) 7.5 (4.2) 7.5 (4.2) 8.8 (4.2) <0.001 <0.001
Age at diagnosis, categorical
0–6 years 32 42 38 42 35
<0.05 NA7–12 years 44 43 52 51 46
13–18 years 24 15 10 7 18
Sex (Females) 47 49 69 60 52 <0.05 NA
pH 7.38 (0.05) 7.25 (0.03) 7.15 (0.03) 6.97 (0.09) 7.27 (0.16) <0.001 <0.001
HbA1c at diagnosis a (mmol/mol) 87 (25.3) 91 (21.2) 93 (19.7) 94 (21.3) 89 (23.6) 0.32 0.03
HbA1c at 12 months b (mmol/mol) 68 (19.2) 69 (17.7) 69 (16.9) 66 (12.8) 68 (17.4) 0.84 0.84
Ethnicity
White 35 30 38 44 36
0.63 NA
Mixed-ethnicity 8 15 14 7 10
Black 23 23 29 18 23
Asian-Other 34 32 19 31 31
Paediatric diabetes Clinic
1 29 25 14 24 26
0.42 NA2 24 32 33 22 26
3 47 43 52 55 48
Treatment c
Insulin pump therapy (%) 12 12 6 14 12 0.73 NA
Number of HbA1c measurements 2.5 (1.4) 2.9 (1.8) 2.5 (1.3) 2.6 (1.4) 2.6 (1.5) 0.06 0.45
Socioeconomic Status (SES) (median) 7367 7481 6474 7767 7367 0.67 NA
Proportion in most deprived
SES quartile 25 27 22 35 27 0.14 NA
a 227 initial HbA1c values measured during the first month post-diagnosis, b 191 HbA1c values measured between
the 10th and 12th months post-diagnosis, c Proportion of subjects on insulin pump therapy 12 months after diagnosis,
d p values are for tests of equal means or proportion, e p values are for tests of trends for continuous outcomes by
categorical DKA (diabetic ketoacidosis) only. NA = Not Applicable. Bold heading: variable name.
Table 2. Factors associated with diabetic ketoacidosis (pH < 7.3) at diagnosis of type 1 diabetes in
364 children and young people attending paediatric diabetes clinics in East London.
Covariate OR (95% CI)
Sex
Male Reference
Female 1.6 (1.1–2.4)
Age at diagnosis
0–6 years 2.9 (1.5–5.6)
7–12 years 2.3 (1.2–4.3)
13–18 years Reference
Ethnicity
White Reference
Mixed-ethnicity 1.1 (0.5–2.3)
Black 0.8 (0.4–1.4)
Asian 0.8 (0.5–1.3)
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Table 2. Cont.
Covariate OR (95% CI)
SES
Quartile 1 (poorest) Reference
Quartile 2 0.8 (0.5–1.5)
Quartile 3 1.2 (0.7–2.1)
Quartile 4 (richest) 0.6 (0.3–1.2)
Text in bold indicates statistical significance at p < 0.05, socioeconomic status.
3.2. Longitudinal Analysis of HbA1c Trajectories by DKA Status (pH Level) at Diagnosis
Mean HbA1c for the study sample at diagnosis was 96 mmol/mol. On average, subjects
experienced a sharp decline in HbA1c in the first two months following diagnosis (−21 mmol/mol,
95% CI−22,−19, Model 2, Table 3). The initial decline in HbA1c (negative linear term,−21 mmol/mol),
was followed by a slight gradual increase in HbA1c (positive quadratic term, 3 mmol/mol) before
a gradual decrease and stabilisation of HbA1c (small negative cubic term, −0.1 mmol/mol, Table 3
and Figure 1). Subjects in the moderate and severe DKA groups had higher HbA1c at diagnosis
(8 mmol/mol and 9 mmol/mol respectively, Model 3, Table 3). Adjustment for covariates did not
significantly affect the estimates for DKA status at diagnosis (moderate DKA; 8, 95% CI 2–14 and
severe DKA; 10 mmol/mol, 4–15, Model 4, Table 3).
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longer apparent after the initial steep decrease in HbA1c (linear term for duration). The moderate and 
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group over 12 months post‐diagnosis. Differences in HbA1c levels by DKA at diagnosis are no longer 
evident from around six months post‐diagnosis. Additionally, differences in HbA1c trajectories by 
severe and moderate DKA were negligible (i.e., trajectories run concurrently).   
Ethnic  minority  groups  had  significantly  higher  HbA1c  at  diagnosis.  The  model  with  all 
covariates, including the interaction term between DKA status and duration, had the best model fit 
(Model 4, Table 3, i.e., the lowest AIC = 10694.27 and −2 LL = 10648.272). 
Figure 1. Linear adjusted and predicted HbA1c trajectories based on DKA status at diagnosis in
364 children and young people diagnosed with type 1 diabetes and attending paediatric diabetes clinics
in East London. DKA: diabetic ketoacidosis.
The test for interaction between DKA at diagnosis and duration on mean HbA1c trajectories was
statistically significant (p = 0.01), indicating initial differences in HbA1c trajectories by DKA was no
longer apparent after the initial steep decrease in HbA1c (linear term for duration). The moderate and
severe DKA groups experienced a small additional decrease in HbA1c (−1 mmol/mol, 95% CI −2,
−0.1 and −1 mmol/mol, −2, −1 respectively) when compared with the normal DKA group during
the first three months. Figure 1 shows the adjusted predicted population average HbA1c trajectories by
DKA group over 12 months post-diagnosis. Differences in HbA1c levels by DKA at diagnosis are no
longer evident from around six months post-diagnosis. Additionally, differences in HbA1c trajectories
by severe and moderate DKA were negligible (i.e., trajectories run concurrently).
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Table 3. Mixed effects models for longitudinal change in glycaemic control (HbA1c) during the first year post-diagnosis of type 1 diabetes in 364 children attending
paediatric diabetes clinics in East London.
Covariates Model 1: RandomIntercept Only
Model 2: Unconditional
Growth Model Plus
Random Slope
Model 3: Plus DKA at
Diagnosis and Interactions
between DKA and Duration
Model 4: Plus All Other
Covariates *
Fixed effects Mean difference in HbA1c,mmol/mol (95% CI)
Mean difference in HbA1c,
mmol/mol (95% CI)
Mean difference in HbA1c,
mmol/mol (95% CI)
Mean difference in HbA1c,
mmol/mol (95% CI)
Constant/intercept
(HbA1c, mmol/mol)
96 (93, 98) 96 (94, 99) 93 (90, 96) 87 (80, 94)
Slope coefficients
Duration in months
Linear −20 (−21, −18) −21 (−22, −19) −20 (−22, −19) −20 (−22, −19)
Quadratic 3 (3, 3) 3 (3, 4) 3 (3, 4) 3 (3, 4)
Cubic −0.1 (−0.2, −0.1) −0.1 (−0.2, −0.1) −0.1 (−0.2, −0.1) −0.1 (−0.2, −0.1)
DKA at diagnosis
Normal (no DKA) Reference
Mild 6 (0, 11) 5 (−1, 10)
Moderate 8 (2, 14) 8 (2, 14)
Severe 9 (3, 15) 10 (4, 15)
Sex
Male Reference
Female −1 (−3, 2)
Age at diagnosis (years) 0.2 (−1, 1)
Ethnicity
White Reference
Mixed-ethnicity 7 (2, 12)
Black 5 (1, 9)
Asian 6 (3, 10)
Treatment type
Non-insulin pump Reference
Insulin pump −7 (−11, −2)
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Table 3. Cont.
Covariates Model 1: RandomIntercept Only
Model 2: Unconditional
Growth Model Plus
Random Slope
Model 3: Plus DKA at
Diagnosis and Interactions
between DKA and Duration
Model 4: Plus All Other
Covariates *
Paediatric Diabetes Clinic
Clinic 1 Reference
Clinic 2 −0.1 (−4, 3)
Clinic 3 5 (1, 8)
Socioeconomic Status 0.1 (−0.1, 1)
Interaction between DKA and duration
Linear * DKA Normal Reference Reference
Linear * DKA Mild −1 (−2, 1) −1 (−1, 1)
Linear * DKA Moderate −1 (−2, −0.1) −1 (−2, −0.1)
Linear * DKA Severe −1 (−2, −0.4) −1 (−2, −1)
Interclass Correlation (ICC) 0.41 0.60 0.58 0.53
Model fit
Aikake information criterion (AIC) 10,790.12 10,725.24 10,721.18 10,694.27
Bayesian information criterion (BIC) 10,821.04 10,766.46 10,793.32 10,812.79
−2 LL 10,778 10,709.22 10,693.182 10,648.272
Likelihood ratio test for model
comparison (p-value) NA <0.0001 <0.01 <0.0001
* Model 4 adjusted for sex, age at diagnosis, ethnicity, SES, treatment type (insulin pump vs. no insulin pump) and pediatric diabetes clinic attended.
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Ethnic minority groups had significantly higher HbA1c at diagnosis. The model with all covariates,
including the interaction term between DKA status and duration, had the best model fit (Model 4,
Table 3, i.e., the lowest AIC = 10694.27 and −2 LL = 10648.272).
3.3. Factors Associated with Glycaemic Control (HbA1c) 12 Months Post-Diagnosis
DKA at diagnosis was not associated with moderate or poor glycaemic control 12 months
post-diagnosis. Factors like age at diagnosis, ethnicity, gender, clinic and treatment type were associated
with glycaemic control. Children diagnosed between 0–6 years of age were at increased risk for
moderate glycaemic control (RRR (Relative risk ratio) 2.3, 95% CI 1.1–4.9, Table 4). Additionally,
Black and mixed ethnicity children were at increased risk for poor glycaemic control compared to
White children (adjusted RRR 5.4, 95% CI 1.7–17.3 and RRR 2.5, 95% CI 1.2–6.0, respectively, Table 4).
Males were at decreased risk for poor glycaemic control.
Table 4. Relative risk ratios (RRR) associated with moderate (HbA1c 58–79 mmol/mol) and poor
glycaemic control (HbA1c ≥80 mmol/mol) 12 months post-diagnosis of type 1 diabetes in 396 children
and young people attending paediatric diabetes clinics in East London.
Glycaemic Control Model 1, MinimallyAdjusted RRR 95% CI
Model 2, Adjusted for
All Covariates RRR 95% CI
Good 1.0 1.0
Moderate
DKA
No (pH ≥ 7.3) 1.0 1.0
Yes (pH < 7.3) 1.0 0.6–1.6 0.8 0.5–1.4
Sex
Females 1.0
Males 0.7 0.4–1.1
Age at diagnosis
0–6 years 2.3 1.1–4.9
7–12 years 1.7 0.8–3.5
13–18 years 1.0
Ethnicity
White 1.0
Mixed-ethnicity 2.3 0.9–5.6
Black 1.0 0.5–1.8
Asian-Other 0.7 0.4–1.3
Treatment type
No insulin pump 1.0
Insulin pump 0.4 0.2–0.8
Paediatric Diabetes Clinic
1 1.0
2 1.2 0.6–2.4
3 0.8 0.4–1.4
Poor
DKA
No (pH ≥ 7.3) 1.0 1.0
Yes (pH < 7.3) 1.0 0.6–1.8 1.1 0.6–2.1
Sex
Females 1.0
Males 0.5 0.2–0.9
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Table 4. Cont.
Glycaemic Control Model 1, MinimallyAdjusted RRR 95% CI
Model 2, Adjusted for
All Covariates RRR 95% CI
Age at diagnosis
0–6 years 0.3 0.1–0.7
7–12 years 0.7 0.3–1.6
13–18 years 1.0
Ethnicity
White 1.0
Mixed-ethnicity 5.4 1.7–17.3
Black 2.5 1.2–6.0
Asian-Other 1.7 0.7–3.9
Treatment type
No insulin pump 1.0
Insulin pump 0.3 0.1–0.9
Paediatric Clinic
1 1.0
2 3.7 1.5–9.0
3 1.5 0.6–3.7
Text in bold indicates statistical significance at p < 0.05. RRR: relative risk ratio.
4. Discussion
In this multi-ethnic cohort, we found females and those diagnosed at younger ages had increased
risk for moderate and severe DKA at initial presentation. Subjects with moderate or severe DKA
presented with higher HbA1c levels. However, differences in early glycaemic control by DKA status
were no longer evident from six months post-diagnosis. Most subjects experienced a steep decline in
HbA1c—the “honeymoon phase”—during the first two months post-diagnosis irrespective of their
initial DKA status. Lastly, in line with longitudinal modelling, initial DKA status was not associated
with glycaemic control one year post-diagnosis, but ethnicity, age, and gender were relevant factors.
Mixed effect modelling allows for the inclusion of a large number of data points even when
the data is ‘unbalanced’ (subjects with differing number of data points measured at different times).
To our knowledge, this is the first study in the UK to investigate associations between pH/DKA at
diagnosis and early glycaemic control using longitudinal modelling as data on pH is not routinely
collected in national datasets. We had near complete data on covariates (sex, age at diagnosis, duration,
and ethnicity). Ethnicity was self-identified which is considered to be the ‘gold standard’ in studies on
ethnicity and health. Data was collected from routine electronic medical records limiting recall and
selection bias.
Limitations include that the study sample was drawn from three diabetes clinics (operating
together as a network since 2012) and results may not be generalizable to the rest of the country.
One cannot exclude the possibility of residual confounding due to other factors impacting glycaemic
control at diagnosis and during follow-up which may interact with ketoacidosis severity including
delayed diagnosis and sociodemographic factors (family structure and family history of diabetes).
As data on insulin doses is not collected, we were unable to investigate potential differences in rates of
transient remission by DKA and ethnicity. Contrary to expectations, SES was not associated with risk
for DKA at diagnosis or with glycaemic control in the longitudinal analysis. A significant proportion
of the study sample was deprived (reflecting the neighbourhoods from which the sample was drawn)
leading to low variability in SES. In a previous study on the same cohort, we found no associations
between SES and pH levels, HbA1c at diagnosis or during follow-up [14]. A significant proportion of
our subjects were missing data on pH levels. However, we found no significant differences between
those excluded because of missing data from those included indicating generalizability of the results to
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the entire study population. Subjects diagnosed abroad or in other clinics in the country were expected
to have missing pH data as their initial medical records were inaccessible.
Our study corroborates associations between younger age at diagnosis and increased risk for
DKA at presentation [2,3,18–20]. Additionally, we found that females have an increased risk for DKA
at diagnosis. However, previous studies report inconsistent associations between gender and risk for
DKA at diagnosis and we can offer no firm hypothesis to explain our observation [3,19]. Åkesson et al.
hypothesise that non-recognition of symptoms in females leading to a later diagnosis and hence greater
disease severity at initial presentation could be a potential explanation [19]. However, we found no
statistical differences in age at diagnosis between males and females. During adolescence, females are
more insulin resistant than males, which may impact on frequency and severity of DKA. However
there was no gender difference between the ages of 13 and 18 years so this is unlikely to be the
explanation. The severity of the autoimmune process and the level of endogenous insulin production
after diagnosis of T1D does not differ between the sexes so this is also unlikely to explain the observed
gender difference [21].
Our cohort is unique with its high proportion of ethnic minorities and social deprivation, so within
this there may be relevant cultural and social factors that impact on the timing of seeking medical
assistance for girls compared with boys but we have no evidence to support this hypothesis.
The proportion of subjects presenting with DKA (41%) is higher than that reported elsewhere
but differences are likely due to the differing cut-offs for DKA [3]. We found no ethnic differences
in DKA severity at diagnosis as reported in a previous UK-based study [22]. However, more recent
studies have not found ethnic differences in prevalence of DKA at diagnosis [3]. High HbA1c levels
at diagnosis, followed by the steep decline during the first two months and the subsequent gradual
increase observed here is similar to that reported elsewhere [23–25]. Additionally, ethnic differences in
initial and 12 months HbA1c levels was previously reported in this cohort and other studies [23].
Few studies have analysed associations between DKA/pH at presentation and glycaemic control
during the first year post-diagnosis limiting comparisons. Åkesson et al. reported a significant inverse
association between pH level and HbA1c at diagnosis in a Swedish cohort but did not report long-term
associations [19]. In a single centre study on Scottish children, Lawes et al. found male patients
with DKA at diagnosis had higher HbA1c six months post-diagnosis, but the study did not report
longitudinal HbA1c trajectories based on DKA at diagnosis [4].
The evidence for a metabolic memory in T1D (the association between early tight glycaemic control
due to intensive treatment and reduced risk for long term micro- and macro-vascular complications
risk and mortality) has highlighted the need to achieve good glycaemic control in the months following
diagnosis [26]. Identifying modifiable predictors of this early glycaemic control would potentially aid
this clinical approach. In addition to socioeconomic and demographic factors (access to health care and
awareness in primary care communities), the severity of DKA at presentation with T1D may partly
be a reflection of endogenous insulin production. For example, children <5 years are more likely to
present in severe DKA and are thought to have a more aggressive autoimmune mediated destruction
of pancreatic beta cells and therefore, potentially reduced endogenous insulin. This is relevant as the
latter is an important predictor of long-term glycaemic control and risk of complications and is also a
target for T1D intervention studies. For those under 5 years of age, our data supports a link between
DKA severity and lower endogenous insulin production (and consequently a shorter “honeymoon
period”) as this age group has increased risk to present with severe DKA and have higher HbA1c at
12 months post-diagnosis.
5. Novelty Statement
Moderate and severe DKA at diagnosis is associated with poorer initial glycaemic control
during the first few months post-diagnosis in a multi-ethnic cohort of children with newly diagnosed
type 1 diabetes.
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DKA severity at diagnosis no longer determines HbA1c trajectories from around six
months post-diagnosis.
Age at diagnosis, gender, ethnicity, and insulin pump use are determining factors for glycaemic
control one year after diagnosis.
Greater focus on education and awareness of T1D in the community, early diagnosis in primary
care, and intensive treatment will improve favourable glycaemic control, especially in younger subjects.
6. Conclusions
This study confirms previous findings that females and younger age is associated with increased
risk for moderate and severe DKA at T1D diagnosis. A novel finding is that moderate and severe
DKA at diagnosis is associated with poorer initial glycaemic control during the first few months after
first clinical presentation. However, the differing HbA1c trajectories by DKA severity are no longer
apparent from six months post-diagnosis. Age, ethnicity, and insulin pump-use appear to be strong
factors determining glycaemic control one year after diagnosis. A greater focus on education and
awareness of T1D in the community, early diagnosis in primary care, and intensive insulin therapy in
order to achieve favourable glycaemic control, especially in younger subjects, will reduce the risk for
short- and long-term outcomes associated with T1D.
Supplementary Materials: The following are available online at www.mdpi.com/1660-4601/15/1/26/s1,
Table S1: Comparison of characteristics between the study population included in the analysis (N = 364) and those
excluded because of missing data on pH (DKA) at diagnosis (N = 126).
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